<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon syndrome</z:e> is characterized by the association of <z:hpo ids='HP_0000965'>livedo reticularis</z:hpo> and cerebral ischemic arterial events (<z:hpo ids='HP_0001297'>stroke</z:hpo> or <z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo>) </plain></SENT>
<SENT sid="1" pm="."><plain>Reported prevalence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> is highly variable </plain></SENT>
<SENT sid="2" pm="."><plain>We conducted this study to compare the clinical and pathologic features of patients with <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon syndrome</z:e> according to the presence or absence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Forty-six consecutive patients with <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon syndrome</z:e> were analyzed </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> were examined by the same dermatologist who classified the livedo of the trunk according to the regularity of the fishnet reticular pattern and according to the thickness of the fishnet reticular pattern (&gt; or = 10 mm = large; &lt; 10 mm = fine) </plain></SENT>
<SENT sid="5" pm="."><plain>Skin biopsies were systematically performed, from both the center and the violaceous netlike pattern in 38 patients </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo>-positive <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon syndrome</z:e> was defined by the presence of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> or abnormal titers of anticardiolipin antibodies on repeated determinations </plain></SENT>
<SENT sid="7" pm="."><plain>Group I consisted of 27 <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo>-negative patients and Group II, of 19 <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo>-positive patients </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients except I in Group II had irregular <z:hpo ids='HP_0000965'>livedo reticularis</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Large <z:e sem="disease" ids="C0085642" disease_type="Disease or Syndrome" abbrv="">livedo racemosa</z:e> was more frequently observed in Group I (89%) than in Group II (21%, p &lt; 0.001) </plain></SENT>
<SENT sid="10" pm="."><plain>On skin biopsy, arteriolar obstruction was detected in only 8 patients (4 in each group) </plain></SENT>
<SENT sid="11" pm="."><plain>The following parameters were not statistically different between the 2 groups: gender, mean age at detection of livedo, mean age at first clinical cerebral event, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:e sem="disease" ids="C0034735" disease_type="Disease or Syndrome" abbrv="">Raynaud phenomenon</z:e>, patients with extracerebral and extracutaneous arterial or arteriolar <z:mp ids='MP_0005048'>thrombosis</z:mp> or stenosis, patients with <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo>, and women with 2 fetal losses or more </plain></SENT>
<SENT sid="12" pm="."><plain>In contrast, <z:hpo ids='HP_0001250'>seizures</z:hpo> (11% in Group I versus 37% in Group II, p &lt; 0.05), <z:hpo ids='HP_0001653'>mitral regurgitation</z:hpo> on echocardiogram (19% versus 53%, p = 0.02), and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> &lt; 150,000/muL (0% versus 42%, p &lt; 0.005) were more frequently observed in Group II </plain></SENT>
<SENT sid="13" pm="."><plain>The number of events per year of follow-up was lower with antiplatelet therapy (0.08 versus 0.5) in Group I, but was not different with anticoagulation (0.056 versus 0.06) </plain></SENT>
<SENT sid="14" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo>-negative and -positive patients with <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon syndrome</z:e> belong to close but different subsets of <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon syndrome</z:e> </plain></SENT>
</text></document>